Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial Authors: Yu-Ting Huang, Hsin-Yeh Lee, Hui-Ching Cheng, Hsin-Lun Yang, Ching-Hsia Hung, Chien-Chou Su, Yu-Tzu Chang, Chien-Yao Sun, Kun-Ling Tsai Published: 2026 ABSTRACT AbstractObjectiveTo compare the effects of eccentric cycling (ECC), concentric cycling (CON), and standard care (CTL) on cardiopulmonary capacity, respiratory health, and quality of life (QoL) in patients with chronic kidney disease (CKD).MethodsThirty-one CKD patients were divided into the CTL, CON, and ECC groups. The CON and ECC groups participated in 8-week, 24-session cycling programs. Outcomes were assessed through cardiopulmonary exercise tests, respiratory function tests, and the 36-Item Short Form Survey Instrument questionnaire.ResultsThe ECC group achieved significant improvements in maximal oxygen uptake, while the CTL group showed a decline. For oxygen uptake efficiency slope, significant changes were observed only in the ECC group, with a group-by-time interaction effect compared to CTL. Furthermore, the ECC group demonstrated the most significant increase in diaphragm movement and a significant increase in diaphragm thickness, with comparisons indicating that ECC outperformed both CTL and CON. Regarding QoL, the ECC group exhibited significantly greater improvements in Physical Component Summary and Mental Component Summary, with statistically significant differences compared with the CTL and CON groups.ConclusionECC is a low-effort, high-benefit exercise modality that significantly enhances cardiopulmonary fitness, respiratory function, and QoL in patients with CKD.Keywords: Chronic kidney disease, Exercise, Cardiopulmonary fitness, Eccentric cycling training GRAPHICAL ABSTRACT INTRODUCTION Chronic kidney disease (CKD) is defined by a glomerular filtration rate (GFR) of <60 mL/min/1.73 m2, the presence of kidney damage markers, or both, persisting for at least 3 months [1]. The progression of CKD is associated with various clinical complications resulting from declining renal function, contributing to poor quality of life and increased morbidity and mortality [2,3]. As GFR declines with CKD progression, patients experience fluid retention, metabolic and endocrine disturbances, cardiovascular changes, and diastolic dysfunction. These alterations contribute to a higher prevalence of pulmonary edema and respiratory muscle dysfunction. Data from the US National Health and Nutrition Examination Survey indicate that restrictive pulmonary dysfunction affects 10% of CKD patients, while obstructive pulmonary dysfunction affects 16%, particularly in stages 1–4 [4,5]. As CKD progresses, systemic inflammation, oxidative stress, and metabolic imbalances disrupt the equilibrium between protein synthesis and degradation, impair mitochondrial function, and lead to muscle wasting and sarcopenia [6]. The weakening of skeletal muscles, including respiratory muscles, reduces gas exchange efficiency and lung function, exacerbating exercise intolerance. These changes contribute to increased fatigue, reduced physical activity, and declines in functional capacity and quality of life. A strong correlation exists between physical activity levels and mortality [7]. Patients with CKD stages 3–5 demonstrate greater sarcopenia and exercise intolerance. Therefore, individualized, progressive, and supervised exercise programs are indicated to improve exercise capacity and related clinical outcomes [8]. Regular low- to moderate-intensity physical activity has been shown to provide benefits for individuals with CKD, including improvements in aerobic and functional capacity and quality of life, without negatively affecting kidney function [9]. Furthermore, combined aerobic and resistance training has been shown to improve muscle function, increase exercise tolerance, and reduce resting systolic blood pressure in CKD patients [10]. Given the strong link between reduced maximal oxygen uptake (VO2 max) and increased mortality in CKD patients, enhancing VO2 max is a key goal of exercise interventions [11]. However, post-exercise fatigue often reduces motivation and leads to poor adherence. Addressing this issue may involve minimizing the perceived effort of physical activity [12]. Eccentric exercise, which requires less oxygen and energy than concentric exercise, offers advantages such as low energy cost, reduced motion perception, and decreased metabolic demand. The lower metabolic demand of eccentric exercise is particularly beneficial for individuals with exercise intolerance, enabling them to engage in higher-intensity training [12]. Eccentric cycling (ECC), a unique form of aerobic exercise, requires four times less cardiorespiratory energy than concentric cycling (CON), improving exercise efficiency at the same perceived exertion while reducing heart rate and oxygen uptake. ECC enhances muscle strength and promotes hypertrophy [13]. Recent discussions on ECC have focused on its application in training programs for specific populations, such as frail individuals and patients with chronic conditions. For instance, studies on patients with chronic obstructive pulmonary disease and chronic heart failure have shown that ECC improves functional capacity and muscle mass more effectively than CON [14-16]. Hypertension and an elevated risk of cardiovascular disease are common in CKD patients. While traditional aerobic exercise can raise blood pressure, increase cardiac workload, and heighten the risk of exercise-related adverse events, eccentric exercise poses lower hemodynamic demands, reducing these risks. This allows individuals with compromised cardiopulmonary function to achieve the necessary exercise intensity safely. As such, ECC may be a more suitable exercise option for CKD patients than traditional CON. However, its effectiveness in this population remains insufficiently studied in existing research. This study aimed to compare the effects of ECC and CON on cardiopulmonary exercise capacity, respiratory function, and quality of life in patients with CKD under identical exercise intensity and duration. Additionally, it evaluated the differences between ECC, CON, and standard healthcare in this population. We hypothesize that ECC will have lower cardiopulmonary and metabolic demands than CON, allowing for a higher exercise load and significantly improving cardiopulmonary exercise capacity, respiratory functions, and quality of life. METHODS Research design and study participants This single-center randomized controlled trial was conducted at the National Cheng Kung University Hospital (NCKUH) in Tainan, Taiwan, between March 2022 and September 2023. It followed the CONSORT (Consolidated Standards of Reporting Trials) statement and was registered on ClinicalTrials.gov (NCT06551311). Ethical approval was obtained from the Institutional Review Board of NCKUH (approval no. A-BR-110-109). All participants provided written informed consent after a detailed explanation of the study procedures. The inclusion criteria for this study were as follows: (1) a GFR <60 mL/min/1.73 m2 with a confirmed diagnosis of CKD; (2) age between 50 and 90 years; (3) ability to comprehend and follow instructions; and (4) capability to walk independently. Exclusion criteria included (1) acute renal failure; (2) hospitalization for an acute illness within the past 3 months; (3) severe joint disease or recent lower extremity surgery; (4) severe neurological conditions; (5) severe cardiovascular disease; and (6) unconsciousness or inability to cooperate during assessments. Thirty-one CKD patients were randomly assigned to one of three groups using a computer-generated sequence with equal allocation: the control group (CTL), which received standard healthcare, the CON group, or the ECC group. The CTL group continued to receive standard medical care according to institutional guidelines, which included routine nephrology follow-up, medication management, nutritional counseling, and received no study-delivered exercise training during the 8-week intervention. They were instructed to maintain their usual physical activity and underwent the same assessments at all study time points as the exercise groups. Baseline assessments were conducted before the initiation of the exercise training program (Time point 1). Midterm assessments were performed after 12 exercise sessions (Time point 2), post-assessments after 24 exercise sessions (Time point 3), and follow-up assessments 4 weeks after the program concluded (Time point 4). All assessments and training sessions were performed under therapist supervision. Interventions: cycling exercise training Participants completed an 8-week cycling exercise program using either a stationary cycle ergometer or an eccentric stationary cycle ergometer (750R; Upwards Biosystems, a recumbent eccentric exercise machine manufactured in Taiwan). Both eccentric and CON were performed on a motor-driven cycle ergometer (750R). CON used the standard concentric mode. ECC used the same ergometer set to the motor-driven eccentric mode, with the cranks driven by the motor and resisted by the participant. The cranks rotate backward, and the rider resists this motion to perform muscle actions, producing large, coordinated eccentric contractions of the knee extensors and the hip extensors and flexors while maintaining the prescribed workload. The initial workload was 50% of peak power output, adjusted to a target Borg rating of perceived exertion (RPE) of 13. This strategy aligns with CKD recommendations for moderate intensity (40%–60% VO2peak) and applies RPE monitoring to harmonize internal load and maintain tolerability and safety [17-19]. Exercise intensity was increased weekly by 5%–10% of the target power, adjusted to maintain an RPE level of 13. Each session lasted 30 minutes and was conducted three times a week for 24 sessions. Fig. 1 illustrates the outline of the current study and the time points at which outcome measurements were taken. Training power output (W) and mechanical work (kJ) were recorded each session. Weekly mean achieved power, weekly mechanical work, and cumulative work across the 8-week program were summarized and are reported in Supplementary Table S1. The schematic outline of this study and the time points of outcome measurements. RPE, rating of perceived exertion; QoL, quality of life. Cardiopulmonary exercise testing Cardiopulmonary exercise testing (CPET) was performed under medical supervision by trained staff in a laboratory equipped for advanced life support. CPET was conducted on an electronically braked cycle ergometer (Ultima CPX; MGC Diagnostics) using an individualized ramp protocol of 15–20 W/min at a cadence of 50–60 rpm, targeting an 8–12 minutes symptom-limited duration. Continuous 12-lead ECG and breath-by-breath gas exchange were recorded. Blood pressure was measured at 2–3 minutes intervals, pulse oximetry was monitored continuously, and Borg 6–20 ratings and symptoms were documented. Tests were terminated at the participant's request or for standard absolute or relative indications, including ischemic ST changes or angina, complex arrhythmias, abnormal blood pressure responses, severe desaturation, or ataxia/cyanosis. Maximal intensity was defined as the symptom-limited peak work rate/VO2, supported by ≥1 objective criterion: respiratory exchange ratio ≥1.10, Borg RPE ≥17/20, or heart rate ≥85%–90% of age-predicted when not rate-limited by β-blockade or devices. Procedures conformed to ATS/ACCP 2003 [19] and ACSM Guidelines 2021. Diaphragm ultrasonography Diaphragm mobility and thickness were evaluated using diaphragm ultrasonography. Participants were positioned in a semi-recumbent position on a 30-degree wedge. Diaphragm excursion at the dome and muscle thickness at the zone of apposition (ZOA) were measured using ultrasound. Each measurement was repeated three times, and the average value was recorded. To minimize operator-dependent variability, all measurements were conducted by a single experienced therapist. These procedures were intended to minimize operator-dependent variability and reduce random error, thereby improving the interpretability of modest absolute changes. Previous methodological reviews indicated good repeatability of diaphragmatic ultrasound when performed by experienced operators using standardized techniques [20]. In this study, all ultrasound assessments were performed by a single trained therapist, using a standardized protocol. The examiner has prior research experience involving diaphragmatic ultrasound as well. Diaphragm excursion was measured during deep breathing. A curved probe (2–5 MHz) from the ultrasound machine (LOGIQ e; GE HealthCare) was placed between the midclavicular and anterior axillary lines below the right costal margin to visualize the diaphragm in M-mode. The displacement of the right diaphragm was recorded by noting the highest point during inhalation and the lowest point during exhalation. Diaphragm thickness was measured at the end of the inspiratory and expiratory phases of breathing, from functional residual capacity to total lung capacity. A linear probe (4–12 MHz) was positioned at the ZOA in the intercostal view between the eighth and ninth intercostal spaces. The diaphragm thickening fraction (TF) was calculated as the percentage difference between the diaphragm thickness at end-inspiration and end-expiration, relative to the thickness at end-expiration. This measurement reflects diaphragm contraction ability [20]. Respiratory muscle strength and pulmonary function test Maximal respiratory pressures were measured during maximal voluntary inhalation and exhalation, following the guidelines of the American Thoracic Society and the European Respiratory Society. Participants were seated upright with a nose clip and used a mouthpiece connected to a pressure meter (GB60; JITTO). The procedure was repeated three times, and the highest value was used for analysis. Spirometry (microQuark; COSMED) was performed as a standard pulmonary function test (PFT) to assess air volume during forced respiratory maneuvers. Key parameters measured include forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio. The participants repeated the measurements 3 times, taking the maximum value as a record as well [21]. Health-related quality of life The 36-Item Short Form Survey Instrument (SF-36) scoring process transforms responses from 36 items into 8 domains: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional health, and mental health. These domains are combined into two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). Statistical analysis The sample size was determined using G*Power software (version 3.1.0), based on a standardized large effect size with a power of 0.80 and an alpha level of 0.05, considering three groups and four measurement time points. Effect size based on a similar workload-matched eccentric versus CON trial reporting meaningful exercise capacity changes. It reported effect sizes used for planning ranging from 0.6 to 1.2 [22]. We selected the lower volume (Cohen’s f: 0.60) to remain conservative. The minimum required total sample size was 21 participants. Therefore, we enrolled 31 participants to account for anticipated withdrawal. A total of 31 participants were enrolled in the study, of whom 22 completed follow-up assessments. Data are presented as mean±standard deviation (SD) for all variables, with a significant level of p<0.05. The Kruskal–Wallis and chi-squared tests assessed baseline differences among the three groups. Data from all randomized participants were included in the longitudinal analyses. Generalized estimating equations (GEE) were applied to analyze intragroup differences across time points 1–4 throughout the intervention. GEE was also used to evaluate intragroup effects over time and group-by-time interaction effects. At baseline, there were significant differences in body mass index (BMI) values across the three groups (Table 1). Since this could influence the calculation and interpretation of results, BMI was included as an adjustment variable when calculating the interaction effect by time group. All data analyses were performed using SPSS software (version 22.0; IBM Corp.). Table 1.Demographic and clinical characteristics of CTL, CON, and ECC groupsDemographic dataCTL group (n=10)CON group (n=10)ECC group (n=11)p-valueAge73.40±10.3074.50±8.9573.18±8.770.923Sex0.958 Male666 Female445Body composition Height (cm)158.35±7.61157.85±11.83159.64±7.800.731 Weight (kg)57.77±8.9467.14±17.5266.78±13.020.116 Body mass index (kg/m2)23.00±2.6526.61±3.5925.97±2.940.028* Body fat27.18±5.6630.94±5.5131.42±4.170.153 Visceral fat8.60±4.9513.70±6.1313.00±6.830.068 Skeletal muscle rate (%)29.71±4.1827.08±3.0727.20±2.540.239 Basal metabolic rate (kcal)1,333.70±187.761,461.60±324.321,447.73±262.370.558Renal function BUN (mg/dL)40.88±25.0035.22±25.0733.64±13.590.782 Creatine (mg/dL)3.04±2.612.66±2.632.16±1.130.899 eGFR (mL/min/1.73 m2)32.51±21.1337.49±18.6634.53±17.620.923Values are presented as mean±standard deviation or number only.Utilized Kruskal–Wallis to compare baseline data across the three groups.Chi-square test was used to compare sex distribution among the three groups.CTL, control; CON, concentric cycling; ECC, eccentric cycling; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate.*p<0.05 intragroup comparison with time effect. Demographic and clinical characteristics of CTL, CON, and ECC groups Values are presented as mean±standard deviation or number only. Utilized Kruskal–Wallis to compare baseline data across the three groups. Chi-square test was used to compare sex distribution among the three groups. CTL, control; CON, concentric cycling; ECC, eccentric cycling; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate. p<0.05 intragroup comparison with time effect. RESULTS Demographic and medical characteristics Thirty-one participants were recruited in the study, with the majority being male (n=18, 58.1%) (Fig. 2). The demographic details are presented in Table 1. No significant differences in age, height, weight, or body composition were found among the three groups. There were also no significant differences in CKD stage or renal blood parameters (data not shown in Table 1). However, BMI showed substantial differences across groups. The clinical profiles of stages 3–5 CKD patients are inherently diverse, as reflected in the significant baseline BMI differences. Therefore, we adjusted for this by including BMI as a covariate in our statistical models. CONSORT (Consolidated Standards of Reporting Trials) study flow diagram of participants in three groups. ECC exercise effectively improves aerobic exercise capacity as measured by CPET, including VO2, oxygen uptake efficiency slope, and minute ventilation to carbon dioxide production Following an 8-week exercise intervention and a 1-month follow-up, the ECC group demonstrated a significant improvement in cardiopulmonary exercise capacity compared to the CTL and CON groups. Furthermore, the group-by-time interaction analysis revealed that the ECC group showed more significant improvements in specific cardiopulmonary parameters (Supplementary Table S2). The VO2 max in the ECC group displayed a consistent upward trend across all groups, with significant intragroup variations (p<0.001, slope=0.113). A significant group-by-time interaction was observed between the ECC and CTL groups (p<0.001). VO2/HR (oxygen pulse) maximal performance was also higher in the ECC group than in the other two groups (p<0.001, slope=0.378). Furthermore, the group-by-time interaction indicated that the ECC group was more beneficial than the CTL (p<0.001) and CON (p<0.001) groups. The minute ventilation to carbon dioxide production (VE/VCO2 slope) values at the anaerobic threshold (AT) and maximal stage showed a downward trend in the ECC group, with statistically significant intragroup differences (AT stage, p<0.001, slope=-0.151; maximal stage, p<0.001, slope=-0.789). Further group-by-time interaction analysis revealed that the ECC group showed statistically significant differences compared to the CTL and CON groups. Moreover, the VE/VCO2 slope showed the greatest decline in the ECC group compared with the other groups, with significant differences from the CTL (p<0.001) and CON (p<0.001) groups. For oxygen uptake efficiency slope (OUES), the CON and ECC groups demonstrated a positive trend over time. A statistically significant improvement was observed only in the ECC group (ECC slope=0.036, p<0.001; CON slope=0.012, p=0.32). Moreover, significant group-by-time interaction was found when comparing the ECC group to the CTL group (ECC vs. CTL, p<0.001) (Fig. 3). Changes in cardiopulmonary exercise testing by groups. (A) VO2 max. (B) OUES. (C) VO2/HR max. (D) VE/VCO2 slope. Data are presented as mean±standard deviation. VO2 max, maximal oxygen uptake; OUES, oxygen uptake efficiency slopeHR, oxygen pulse; VE/VCO2, minute ventilation to carbon dioxide production; CTL, control; CON, concentric cycling; ECC, eccentric cycling; Time point 1, baseline; Time point 2, 1st month; Time point 3, 2nd month; Time point 4, one-month follow-up. *p<0.05 between group comparison with group by time interaction effect. ECC improves respiratory functions, enhances diaphragm thickening and expiratory muscle strength All three groups showed improvements in diaphragm excursion, with the ECC group demonstrating the most significant increase (p=0.001, slope=3.561). Regarding diaphragm thickness fraction, only the ECC group displayed a positive trend and significant intragroup differences (p=0.045, slope=14.585). The between-group analysis showed significant differences between the ECC and the other two groups (ECC vs. CTL, p<0.001) (Fig. 4). In conclusion, diaphragmatic ultrasound results indicated that the ECC group showed the greatest and most statistically significant enhancement. We recognize that diaphragm TF is relatively sensitive to operator technique and breathing pattern, and that small randomized controlled trials may show modest absolute changes with comparatively large SDs. To limit random error, we obtained three measurements for each ultrasound parameter and averaged; a single trained assessor conducted all exams using a standardized protocol. Next, we paid attention to studying respiratory muscle strength in CKD subjects, we found that the CON group showed the most significant improvement in maximal inspiratory pressure (MIP) over time (p<0.001, slope=-5.79). The ECC group had the second-largest improvement, while the CTL group showed the least improvement, with significant intragroup differences (p<0.001, slope=3.401). In addition, the CTL group experienced the most significant decline in maximal expiratory muscle strength at the end of the study, whereas the ECC group had the most minor reduction (CTL, p=0.705, slope=-8.553; ECC, p=0.229, slope=-0.0249). We, therefore, turned to studying the lung function in CKD subjects. The PFT results revealed that the ECC group outperformed the other two groups in percentage predicted FVC (p=0.001, slope=1.364). The ECC group also performed better in percentage predicted FEV1 compared to the other groups (p=0.195, slope=1.204), though no significant group-by-time interaction effect was observed. Notably, the CTL group showed the most favorable overall trend in the percentage predicted FEV1/FVC among the three groups (p<0.001, slope=1.71) (Supplementary Table S3). Changes in diaphragmatic ultrasound by groups. (A) Diaphragm excursion. (B) Diaphragm TF. Data are presented as mean±standard deviation. TF, thickness fraction; CTL, control; CON, concentric cycling; ECC, eccentric cycling; Time point 1, baseline; Time point 2, 1st month; Time point 3, 2nd month; Time point 4, one-month follow-up. *p<0.05 between group comparison with group by time interaction effect. ECC exercise’s impact on quality-of-life Each group showed varying changes across the eight subitems. The ECC group demonstrated noticeable improvements in seven items, making it the most improved group overall. The ECC group demonstrated the most significant improvement in PCS and MCS scores, with statistically significant differences compared to the CTL and CON groups. For PCS, the results were as follows: ECC (p<0.001, slope=4.252), CON (p<0.001, slope=-5.371), and CTL (p<0.001, slope=3.572). For MCS, significant differences were observed between ECC and CTL (p=0.003) and between ECC and CON (p=0.01) (Supplementary Table S4). DISCUSSION As CKD progresses, physical activity decreases, resulting in a reduced quality of life and increased morbidity and mortality. Studies have shown that regular exercise improves cardiopulmonary, neuromuscular, and cognitive functions in CKD patients, enhancing their quality of life and lowering health risks at all stages of the disease. Despite these benefits, the adoption of exercise programs in clinical settings remains limited [23-25]. Therefore, this study aimed to create a new exercise model based on existing research to identify a more effective training strategy for CKD patients. The findings show that an 8-week ECC program significantly improved aerobic exercise capacity, pulmonary functions, and quality-of-life in individuals with stage 3–5 CKD. Exercise has shown a significant impact on cardiorespiratory function in CKD patients [26]. A previous study indicated that exercising three times per week for 3 months significantly improved VO2 in CKD patients, with even more significant improvements in programs lasting over 6 months [10]. Our results align with these findings. Both exercise intervention groups (ECC and CON) showed significant increases in VO2 max over time. Additionally, a VO2 peak exceeding 17.5 mL/min/kg strongly predicts survival in CKD patients [27]. Although neither group reached the 17.5 mL/min/kg threshold, both surpassed the clinically significant difference of 1.5 mL/min/kg [28] when comparing the experimental endpoint to the baseline. In contrast, the CTL group showed a significant decline by the experimental endpoint, with significant group-by-time interaction effects observed between the CTL and ECC groups and the CTL and CON groups. These results indicate that exercise interventions improve VO2 max performance. Notably, the VO2 max improvement appeared greater in the CON group than in the ECC group, suggesting the need for further research into the validity of the OUES as an alternative indicator. OUES is an objective and reproducible method for assessing cardiopulmonary function, serving as a novel indicator of cardiopulmonary functional reserve. It provides stable numerical performance throughout the CPET and reflects the relationship between oxygen uptake and minute ventilation. Combining respiratory, cardiovascular, and musculoskeletal functions into a single index, OUES may offer a more practical and safer alternative to maximal exercise testing, particularly for high-risk patients, such as those with heart failure or CKD [29-32]. A study on patients with end-stage renal disease (ESRD) undergoing hemodialysis after 20 weeks of aerobic exercise training (three times per week) showed that OUES and VO2 were significantly higher in the training group than in the CTL. Additionally, OUES was strongly correlated with changes in VO2 max (r=0.78, p<0.001) [32]. This supports the findings of our study, where the ECC group showed the most significant increase in OUES, which was significantly higher than that of the CTL group. One possible reason for the increase in OUES is a smaller rise in lactate production during exercise. Research has demonstrated that physical training reduces exercise-induced metabolic acidosis, with similar effects observed in both healthy individuals and patients with heart failure [33]. ECC involves muscles working against resistance while lengthening, unlike CON, where muscles shorten during contraction. The efficiency of eccentric contractions enables higher force production with lower energy expenditure, thereby reducing metabolic costs and minimizing lactate accumulation. Moreover, ECC results in a lower cardiopulmonary response at the same absolute power output than CON, leading to decreased blood lactate levels [34,35]. Our experimental results support these findings, demonstrating that cycling training effectively enhances the cardiopulmonary exercise capacity of patients with CKD. ECC enhances the benefits of the OUES by reducing metabolic costs and cardiopulmonary demands more than CON. Decreased lung function and exercise tolerance in patients with CKD are closely linked to disease progression, malnutrition, anemia, a sedentary lifestyle, and muscle atrophy. Research has shown that reduced contractility in skeletal muscles may also affect respiratory muscles, leading to reduced respiratory muscle strength and worsening ventilation limitations, which further impair respiratory function [36,37]. A study involving patients undergoing hemodialysis at the ESRD stage found that, during dialysis, they completed 24 high-intensity CON exercise sessions, three times per week over 8 weeks. The training group showed better outcomes than the CTL in all respiratory-related measures, including the 6-minute walk test, maximum respiratory pressure, and PFT [36]. We found that the ECC group exhibited the best diaphragm function among the three groups, particularly in diaphragm excursion and diaphragm TF. The diaphragm TF in the ECC group showed significantly more improvement than the CTL and CON groups, highlighting a clear advantage in this measure. While the absolute improvements in diaphragm parameters were modest, the statistical robustness observed suggests that ECC provides a tangible physiological stimulus to the respiratory muscles. These small magnitude changes in ultrasound measures are common in chronic disease populations but are clinically meaningful when associated with improved functional capacity and reduced fatigue. Moreover, the ECC group demonstrated superior maximal expiratory pressure compared to the other groups, further supporting the effectiveness of this intervention. These results differ from those of previous studies, likely due to differences in the type of cycling training used in those studies. Although ECC training has improved muscle strength and functional capacity, its direct effects on respiratory muscle strength are less well-documented than inspiratory muscle training. Unlike targeted respiratory muscle training, which directly focuses on respiratory muscles, ECC primarily enhances skeletal muscle strength, functional capacity, and athletic performance. While it indirectly benefits respiratory function, it may not improve respiratory muscle strength to the same degree as specific respiratory muscle training. However, its lower cardiorespiratory demands and enhanced exercise tolerance help reduce fatigue, allowing for more sustainable exercise to maintain or improve respiratory muscle function over time [15]. Our findings support this phenomenon. Despite not directly targeting respiratory muscles, the reduced metabolic demands of eccentric exercise allow for a higher overall training volume, contributing to improvements in respiratory muscle function, as seen in enhanced diaphragm performance. Physical activity levels in patients with CKD typically decline as the disease progresses, leading to a reduced quality of life and increased mortality [38]. A previous study showed that a 12-week renal rehabilitation program significantly improved the quality of life in CKD stages 3 and 4, as measured by the SF-36 scale [39]. Additionally, the Dialysis Outcomes and Practice Patterns Study found that higher exercise frequency was positively associated with improvements in both the MCS and PCS scores of the Kidney Disease Quality-of-Life Short Form in hemodialysis patients [40]. In our study, the ECC group showed an improvement trend in both PCS and MCS scores on the SF-36 scale. Notably, the MCS exhibited the greatest improvement among the three groups, with statistically significant differences compared to the other two groups. Further analysis revealed that, within the “Vitality” item, the ECC group experienced a significant increase, with significant differences observed both within and between groups. These findings suggest that ECC may be more effective in enhancing vitality and overall quality of life in CKD patients. This study has several limitations. First, the sample size of our study is relatively small, which increases the risk of attrition bias. Second, baseline BMI differences persisted despite adjustment, which may affect statistical power and the generalizability of our findings to the broader CKD population. Third, the 8-week intervention and 4-week follow-up are too short to establish durability, safety, or effects on hard clinical outcomes. Finally, the narrowly defined non-dialysis CKD cohort and use of a single ergometer model constrain reproducibility and broader applicability; larger multicenter trials with longer follow-up are warranted. In conclusion, our study is the first to investigate the impact of ECC exercise on cardiopulmonary function in patients with CKD. The results show that an 8-week ECC training program significantly improves cardiopulmonary exercise capacity, respiratory functions, and quality of life. Furthermore, ECC showed favorable changes compared with CTL and comparable improvements to CON, with between-group advantages on selected outcomes. Importantly, no adverse effects were observed during the study. These findings offer preliminary evidence supporting ECC exercise as a potential new intervention for CKD patients. Footnotes CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. FUNDING INFORMATION This study was supported by the Ministry of Science and Technology of Taiwan (MOST-111-2628-B-006-015-MY3) and National Science and Technology Council of Taiwan (NSTC-113-2410-H-024-012-MY2) ; however, the funding agency did not participate in the study design, data collection and analysis, report writing, or the decision to submit the report for publication. AUTHOR CONTRIBUTION Conceptualization: Huang YT, Lee HY, Yang HL, Sun CY. Data curation: Huang YT, Cheng HC, Su CC. Resources: Huang YT, Chang YT. Validation: Huang YT, Lee HY, Hung CH, Chang YT, Sun CY. Formal analysis: Lee HY, Cheng HC, Chang YT, Sun CY. Project administration: Lee HY, Hung CH, Tsai KL. Funding acquisition: Cheng HC. Investigation: Yang HL, Hung CH, Chang YT, Tsai KL. Methodology: Yang HL. Supervision: Hung CH, Su CC, Sun CY. Software: Su CC. Visualization: Tsai KL. Writing – original draft: Huang YT, Sun CY, Tsai KL. Writing – review & editing: Tsai KL. Approval of final manuscript: all authors. DATA AVAILABILITY STATEMENT The data supporting this study's findings are available from the corresponding author upon reasonable request. SUPPLEMENTARY MATERIALS Supplementary materials can be found via https://doi.org/10.5535/arm.250163. Supplementary Table S1. Mechanical work record Supplementary Table S2. Cardiopulmonary exercise testing (CPET) Supplementary Table S3. Respiratory functions Supplementary Table S4. 36-Item Short Form Survey Instrument (SF-36) REFERENCES Associated Data Supplementary Materials Supplementary Table S1. Mechanical work record Supplementary Table S2. Cardiopulmonary exercise testing (CPET) Supplementary Table S3. Respiratory functions Supplementary Table S4. 36-Item Short Form Survey Instrument (SF-36)